Resources from the same session
Introduction: Why differentiation matters
Presenter: Suzanne George
Session: The even rarer sarcomas: Treating the untreatable
Resources:
Slides
Webcast
Offering treatment without evidence and financial coverage
Presenter: Silvia Stacchiotti
Session: The even rarer sarcomas: Treating the untreatable
Resources:
Slides
Webcast
Clinical trials for the ultra-rare cancers: The regulator’s perspective
Presenter: Ralf Herold
Session: The even rarer sarcomas: Treating the untreatable
Resources:
Slides
Webcast
Conclusions and perspectives
Presenter: Maud Toulmonde
Session: The even rarer sarcomas: Treating the untreatable
Resources:
Slides
Webcast